Kirkeby A - Search Results

1

Risk-based pricing models and the role they might play in patients' access to new stem cell therapies.

Hoeyer K, Borsch AS, Jensen KB, Kirkeby A, Steenholdt C, Wadmann S. Hoeyer K, et al. Among authors: kirkeby a. Regen Med. 2024 Dec;19(12):589-593. doi: 10.1080/17460751.2024.2441642. Epub 2024 Dec 18. Regen Med. 2024. PMID: 39691034

2

Predictive Markers Guide Differentiation to Improve Graft Outcome in Clinical Translation of hESC-Based Therapy for Parkinson's Disease.

Kirkeby A, Nolbrant S, Tiklova K, Heuer A, Kee N, Cardoso T, Ottosson DR, Lelos MJ, Rifes P, Dunnett SB, Grealish S, Perlmann T, Parmar M. Kirkeby A, et al. Cell Stem Cell. 2017 Jan 5;20(1):135-148. doi: 10.1016/j.stem.2016.09.004. Epub 2016 Oct 27. Cell Stem Cell. 2017. PMID: 28094017 Free PMC article.

3

Functional and immunochemical characterisation of different antibodies against the erythropoietin receptor.

Kirkeby A, van Beek J, Nielsen J, Leist M, Helboe L. Kirkeby A, et al. J Neurosci Methods. 2007 Aug 15;164(1):50-8. doi: 10.1016/j.jneumeth.2007.03.026. Epub 2007 Apr 12. J Neurosci Methods. 2007. PMID: 17524492

4

Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor.

Jönsson ME, Nelander Wahlestedt J, Åkerblom M, Kirkeby A, Malmevik J, Brattaas PL, Jakobsson J, Parmar M. Jönsson ME, et al. Among authors: kirkeby a. Development. 2015 Sep 15;142(18):3166-77. doi: 10.1242/dev.122747. Development. 2015. PMID: 26395143 Free PMC article.

5

The stem cell niche finds its true north.

Kirkeby A, Perlmann T, Pereira CF. Kirkeby A, et al. Development. 2016 Aug 15;143(16):2877-81. doi: 10.1242/dev.140095. Development. 2016. PMID: 27531947 Review.

6

hESC-derived neural progenitors prevent xenograft rejection through neonatal desensitisation.

Heuer A, Kirkeby A, Pfisterer U, Jönsson ME, Parmar M. Heuer A, et al. Among authors: kirkeby a. Exp Neurol. 2016 Aug;282:78-85. doi: 10.1016/j.expneurol.2016.05.027. Epub 2016 May 25. Exp Neurol. 2016. PMID: 27235932 Free PMC article.

7

Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.

Montero M, Poulsen FR, Noraberg J, Kirkeby A, van Beek J, Leist M, Zimmer J. Montero M, et al. Among authors: kirkeby a. Exp Neurol. 2007 Mar;204(1):106-17. doi: 10.1016/j.expneurol.2006.09.026. Epub 2006 Dec 8. Exp Neurol. 2007. PMID: 17157835

8

Clinical translation of pluripotent stem cell-based therapies: successes and challenges.

Christiansen JR, Kirkeby A. Christiansen JR, et al. Among authors: kirkeby a. Development. 2024 Apr 1;151(7):dev202067. doi: 10.1242/dev.202067. Epub 2024 Apr 2. Development. 2024. PMID: 38564308 Free PMC article.

9

Pluripotent stem-cell-derived therapies in clinical trial: A 2025 update.

Kirkeby A, Main H, Carpenter M. Kirkeby A, et al. Cell Stem Cell. 2025 Jan 2;32(1):10-37. doi: 10.1016/j.stem.2024.12.005. Cell Stem Cell. 2025. PMID: 39753110 Free article. Review.

10

Current advancements of modelling schizophrenia using patient-derived induced pluripotent stem cells.

Dubonyte U, Asenjo-Martinez A, Werge T, Lage K, Kirkeby A. Dubonyte U, et al. Among authors: kirkeby a. Acta Neuropathol Commun. 2022 Dec 16;10(1):183. doi: 10.1186/s40478-022-01460-2. Acta Neuropathol Commun. 2022. PMID: 36527106 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters